Banner

Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Diverticulitis Disease Global Market Report 2024

Diverticulitis Disease Global Market Report 2024 – By Type (Uncomplicated, Complicated), By Diagnosis (Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test), By Treatment (Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids), By End-User (Specialty Centers, Hospitals, Research centers) – Market Size, Trends, And Global Forecast 2024-2033

Diverticulitis Disease Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Diverticulitis Disease Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Diverticulitis Disease Market Definition

Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding.

The main types of diverticulitis disease are uncomplicated and complicated. Uncomplicated diverticulitis refers to a medical condition characterized by inflammation or infection of small pouches (diverticula) that can form in the walls of the colon. The types of diagnosis are included, such as computed tomography (CT) scans, ultrasounds, urine tests and blood tests, that includes treatments types such as medications, surgery, supportive care, penicillin antibiotic, antibiotics, dietary supplements and intravenous (IV) fluids. It is used by several end-users, such as specialty centers, hospitals and research centers.

Diverticulitis Disease Market Segmentation

The diverticulitis disease market covered in this report is segmented –

1) By Type: Uncomplicated; Complicated

2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test

3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids

4) By End-User: Specialty Centers; Hospitals; Research centers

Global Diverticulitis Disease Market Size 2023 to 2028: Graph

Diverticulitis Disease Market Size 2024 And Growth Rate

The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.

Diverticulitis Disease Market Growth Forecast

The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.

Book your 30 minutes free consultation with our research experts

Contact Us

Diverticulitis Disease Market Driver: Increasing Demand For Diverticulitis Treatments Driven By Rising Digestive Disorders

Rising demand for drugs and treatments for digestive disorders is expected to propel the growth of the diverticulitis disease market going forward. Digestive disorders refer to a wide range of conditions that affect the digestive system, which is responsible for breaking down and absorbing nutrients from food. Digestive disorders, such as colorectal cancer, can increase the risk of diverticulitis by contributing to the formation of diverticula and promoting bacterial stagnation in the colon's pouches. For instance, in September 2022, according to the International Agency for Research on Cancer, a France-based government agency, it was estimated that by 2040, there would be 3.2 million new cases and 1.6 million deaths attributed to colorectal cancer each year, representing a significant increase from 1.9 million newly diagnosed patients and 930,000 deaths in 2020. Therefore, the rising demand for drugs and treatments for digestive disorders is driving the growth of the diverticulitis disease market.

Diverticulitis Disease Market Driver: Increasing Prevalence Of Inflammatory Bowel Diseases Fuels Growth In The Market

The increasing prevalence of inflammatory bowel diseases is expected to propel the growth of the diverticulitis disease market going forward. Inflammatory bowel disease (IBD) is a group of chronic inflammatory disorders primarily affecting the gastrointestinal (GI) tract. Diverticulitis can initially mimic IBD, and there is evidence of low-grade chronic inflammation in people with diverticula. Diverticulitis is thought to be caused by mucosal inflammation caused by immune system activation. For instance, in May 2021, according to BioMed Central Ltd., a UK-based scientific open-access publisher, it is expected that between 2020 and 2035, there will be 69 thousand Inflammatory bowel disease cases in Iran, 220 thousand cases in the Middle East, 2.2 million cases in India and 4.5 million cases in East Asia. Therefore, the increasing prevalence of inflammatory bowel diseases drives the diverticulitis disease market.

Elevated Healthcare Expenditure Fosters Advances In Diverticulitis Disease Care

The rise in healthcare expenditures is expected to propel the growth of the diverticulitis disease market going forward. Health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs and emergency help focusing on health. A rise in healthcare expenditure plays a significant role in developing more effective therapies and medical technologies for diverticulitis disease. For instance, in December 2022, according to the Centers for Medicare & Medicaid Services, a US-based federal agency, spending on health care in the United States increased by 2.7% to $12,914 per person in 2021, or $4.3 trillion. Moreover, spending on healthcare accounted for 18.3 percent of the country's GDP. Furthermore, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2020 and 2021, healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. Additionally, spending on preventive care was $45.72 billion in 2021, more than doubling from 2020. Therefore, the rise in healthcare expenditures is driving the growth of the diverticulitis disease market.

Global Diverticulitis Disease Market Major Players

Major players in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

Global Diverticulitis Disease Market Restraint: Lack Of Awareness About The Disease Impacted The Diverticulitis Disease Market Growth

Lack of awareness about the disease is expected to hinder the growth of the diverticulitis disease market going forward. A lack of awareness about diverticulitis among people can lead to a delay in diagnosis and treatment, which can further worsen the condition. For instance, in June 2023, according to the National Library of Medicine, a US-based medical library, many people who experienced symptoms such as pain in the lower left abdomen, fever, nausea and vomiting, diarrhea, and lack of appetite delayed seeking care because they’re embarrassed or they fear that gastrointestinal surgery with a colostomy bag will be their only treatment option. Therefore, a lack of awareness about the disease is hindering the growth of the diverticulitis disease market.

Global Diverticulitis Disease Market Trend: Innovative Drug Development Spurs Advances In Diverticulitis Treatments

Major companies operating in the diverticulitis disease market are developing innovative drugs and getting them approved to sustain their position in the market. Drug development can lead to the development of more effective treatments for diverticulitis, reducing the risk of complications and improving patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, approved Seres' microbiota drug for recurrent gut infections. This drug is designed to treat recurring gut infections and prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst was based on a clinical trial that enrolled 346 patients with recurrent CDI. The trial found that patients who received Vowst were significantly less likely to experience a recurrence of the infection than those who received a placebo. The drug is taken orally and is based on microbiota containing Firmicutes spores, which are known to contribute to a healthy microbiome that can resist C. diff. colonization.

Regional Outlook For The Global Diverticulitis Disease Market

North America was the largest region in the diverticulitis disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the diverticulitis disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diverticulitis disease market consists of revenues earned by entities by providing diagnostic services, pain management, nutritional therapy and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diverticulitis disease market also includes sales of antibiotics, dietary supplements, high-fiber foods and pain medications. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The diverticulitis disease market research report is one of a series of new reports from The Business Research Company that provides diverticulitis disease market statistics, including diverticulitis disease industry global market size, regional shares, competitors with a diverticulitis disease market share, detailed diverticulitis disease market segments, market trends and opportunities and any further data you may need to thrive in the diverticulitis disease industry. This diverticulitis disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Diverticulitis Disease Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.85 billion
Revenue Forecast In 2033 $2.65 billion
Growth Rate CAGR of 9.4% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Uncomplicated, Complicated
2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test
3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids
4) By End-User: Specialty Centers, Hospitals, Research centers
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Abbott Laboratories; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Astellas Pharma; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Otsuka Pharmaceutical Company; Cipla Limited; Hikma Pharmaceuticals PLC; Endo Pharmaceuticals; Aspen Pharmacare; Zydus Lifesciences; Lupin Limited; Glenmark Pharmaceuticals; Alkem Laboratories; Torrent Pharmaceuticals Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Diverticulitis Disease Market Characteristics

    3. Diverticulitis Disease Market Trends And Strategies

    4. Diverticulitis Disease Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Diverticulitis Disease Market Size and Growth

    5.1. Global Diverticulitis Disease Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Diverticulitis Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Diverticulitis Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Diverticulitis Disease Market Segmentation

    6.1. Global Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Uncomplicated

    Complicated

    6.2. Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Computed Tomography (CT) Scan

    Ultrasound

    Urine Test

    Blood Test

    6.3. Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Medications

    Surgery

    Supportive care

    Penicillin Antibiotic

    Antibiotics

    Dietary Supplements

    Intravenous (IV) Fluids

    6.4. Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Specialty Centers

    Hospitals

    Research centers

    7. Diverticulitis Disease Market Regional And Country Analysis

    7.1. Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Diverticulitis Disease Market  

    8.1. Asia-Pacific Diverticulitis Disease Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Diverticulitis Disease Market  

    9.1. China Diverticulitis Disease Market Overview  

    9.2. China Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Diverticulitis Disease Market  

    10.1. India Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Diverticulitis Disease Market  

    11.1. Japan Diverticulitis Disease Market Overview  

    11.2. Japan Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Diverticulitis Disease Market  

    12.1. Australia Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Diverticulitis Disease Market  

    13.1. Indonesia Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Diverticulitis Disease Market  

    14.1. South Korea Diverticulitis Disease Market Overview  

    14.2. South Korea Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Diverticulitis Disease Market  

    15.1. Western Europe Diverticulitis Disease Market Overview

    15.2. Western Europe Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Diverticulitis Disease Market  

    16.1. UK Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Diverticulitis Disease Market  

    17.1. Germany Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Diverticulitis Disease Market  

    18.5. France Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Diverticulitis Disease Market  

    19.9. Italy Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Diverticulitis Disease Market  

    20.13. Spain Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Diverticulitis Disease Market  

    21.1. Eastern Europe Diverticulitis Disease Market Overview

    21.2. Eastern Europe Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Diverticulitis Disease Market  

    22.1. Russia Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Diverticulitis Disease Market  

    23.1. North America Diverticulitis Disease Market Overview

    23.2. North America Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Diverticulitis Disease Market  

    24.1. USA Diverticulitis Disease Market Overview

    24.2. USA Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Diverticulitis Disease Market  

    25.1. Canada Diverticulitis Disease Market Overview

    25.2. Canada Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Diverticulitis Disease Market  

    26.1. South America Diverticulitis Disease Market Overview

    26.2. South America Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Diverticulitis Disease Market  

    27.1. Brazil Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Diverticulitis Disease Market  

    28.1. Middle East Diverticulitis Disease Market Overview

    28.2. Middle East Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Diverticulitis Disease Market  

    29.1. Africa Diverticulitis Disease Market Overview

    29.2. Africa Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Diverticulitis Disease Market Competitive Landscape And Company Profiles

    30.1. Diverticulitis Disease Market Competitive Landscape

    30.2. Diverticulitis Disease Market Company Profiles

    30.2.1. Pfizer Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Johnson and Johnson

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. F. Hoffmann-La Roche AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Merck & Co. Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AbbVie Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Diverticulitis Disease Market Other Major And Innovative Companies

    31.1. Bayer AG

    31.2. Novartis AG

    31.3. Sanofi S.A.

    31.4. Bristol-Myers Squibb Company

    31.5. AstraZeneca plc

    31.6. Abbott Laboratories

    31.7. GlaxoSmithKline plc

    31.8. Takeda Pharmaceutical Company Limited

    31.9. Eli Lilly and Company

    31.10. Amgen Inc.

    31.11. Viatris Inc.

    31.12. Teva Pharmaceutical Industries Ltd.

    31.13. Astellas Pharma

    31.14. Eisai Co. Ltd.

    31.15. Sun Pharmaceutical Industries Ltd.

    32. Global Diverticulitis Disease Market Competitive Benchmarking

    33. Global Diverticulitis Disease Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Diverticulitis Disease Market

    35. Diverticulitis Disease Market Future Outlook and Potential Analysis

    35.1 Diverticulitis Disease Market In 2028 - Countries Offering Most New Opportunities

    35.2 Diverticulitis Disease Market In 2028 - Segments Offering Most New Opportunities

    35.3 Diverticulitis Disease Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Pfizer Inc. Financial Performance
  • Table 76: Johnson and Johnson Financial Performance
  • Table 77: F. Hoffmann-La Roche AG Financial Performance
  • Table 78: Merck & Co. Inc. Financial Performance
  • Table 79: AbbVie Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Diverticulitis Disease Market, Segmentation By  Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Pfizer Inc. Financial Performance
  • Figure 76: Johnson and Johnson Financial Performance
  • Figure 77: F. Hoffmann-La Roche AG Financial Performance
  • Figure 78: Merck & Co. Inc. Financial Performance
  • Figure 79: AbbVie Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

Read More

How Will The Nuclear Medicine Market Grow In 2022?

Read More

What Is The Pediatric Imaging Market Overview In 2022?

Read More

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Read More

Inflammatory Bowel Disease Treatment Global Market Report 2024 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 – By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Cancer Drugs Global Market Report 2024 – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Specialty Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Volvulus Treatment Global Market Report 2024 – By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), By Treatment Type (Medication, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Cancer Diagnostic Procedure Global Market Report 2024 – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types ), By Symptom Type (Symptomatic, Asymptomatic), By Offering Type (Instruments, Reagents and Consumables, Services), By Body Fluid Type (Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid), By Disease Indication (Early Gastric Cancer, Advanced Gastric Cancer) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antacids Global Market Report 2024 – By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Formulation Type (Tablet, Liquid, Powder, Other Formulation Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digestive Health Global Market Report 2024 – By Product Type (Functional Foods and Beverages, Vitamins and Dietary Supplements, Other Products), By Ingredient Type (Probiotics, Prebiotics, Digestive Enzymes, Other Ingredients), By Distribution Channel (Supermarkets/Hypermarkets, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digestive Health Supplements Global Market Report 2024 – By Product (Prebiotics, Probiotics, Enzymes, Fulvic Acid, Other Product), By Form (Capsules, Tablets, Powders, Liquids, Other Form), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Store, Specialty Store, Pharmacies, E-Commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the diverticulitis disease market?

Diverticulitis disease refers to a medical condition characterized by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. The symptoms of diverticular disease include lower abdominal pain, constipation, diarrhea and rectal bleeding. request a sample here

How will the diverticulitis disease market drivers and restraints affect the diverticulitis disease market dynamics? What forces will shape the diverticulitis disease industry going forward?

The diverticulitis disease market major growth driver - Increasing Demand For Diverticulitis Treatments Driven By Rising Digestive Disorders. request a sample here

What is the forecast market size or the forecast market value of the diverticulitis disease market?

The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging. The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes. request a sample here

How is the diverticulitis disease market segmented?

The diverticulitis disease market is segmented
1) By Type: Uncomplicated, Complicated
2) By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test
3) By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids
4) By End-User: Specialty Centers, Hospitals, Research centersFor further insights on the diverticulitis disease market request a sample here

Which region has the largest share of the diverticulitis disease market? What are the other regions covered in the report?

North America was the largest region in the diverticulitis disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the diverticulitis disease market?

Major players in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd. request a sample here.

What are the key trends in the diverticulitis disease market?

Major trend in the diverticulitis disease market - Innovative Drug Development Spurs Advances In Diverticulitis Treatments. request a sample here.

What are the major opportunities in the diverticulitis disease market? What are the strategies for the diverticulitis disease market?

For detailed insights on the major opportunities and strategies in the diverticulitis disease market, request a sample here.

How does the diverticulitis disease market relate to the overall economy and other similar markets?

For detailed insights on diverticulitis disease market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the diverticulitis disease industry?

For detailed insights on the mergers and acquisitions in the diverticulitis disease industry, request a sample here.

What are the key dynamics influencing the diverticulitis disease market growth? SWOT analysis of the diverticulitis disease market.

For detailed insights on the key dynamics influencing the diverticulitis disease market growth and SWOT analysis of the diverticulitis disease industry, request a sample here.